Anthracyclines in Early Breast Cancer: The ABC Trials—USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology)

PURPOSE: Docetaxel and cyclophosphamide (TC) was superior to doxorubicin and cyclophosphamide (AC) in a trial in early breast cancer. However, activity of TC relative to AC regimens with a taxane (TaxAC) is unknown. METHODS: In a series of three adjuvant trials, women were randomly assigned to TC fo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Main Authors: Blum, Joanne L., Flynn, Patrick J., Yothers, Greg, Asmar, Lina, Geyer, Charles E., Jacobs, Samuel A., Robert, Nicholas J., Hopkins, Judith O., O'Shaughnessy, Joyce A., Dang, Chau T., Gómez, Henry Leonidas, Fehrenbacher, Louis, Vukelja, Svetislava J., Lyss, Alan P., Paul, Devchand, Brufsky, Adam M., Jeong, Jong-Hyeon, Colangelo, Linda H., Swain, Sandra M., Mamounas, Eleftherios P., Jones, Stephen E., Wolmark, Norman
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2017
Assuntos:
ORIGINAL REPORTS
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5549453/
https://ncbi.nlm.nih.gov/pubmed/28398846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.71.4147
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares